SignaBlok, in collaboration with the University of Texas at Tyler, awarded NHLBI / NIH CATALYZE grant to develop a novel treatment for pleural infection (empyema)

SignaBlok > News > SignaBlok, in collaboration with the University of Texas at Tyler, awarded NHLBI / NIH CATALYZE grant to develop a novel treatment for pleural infection (empyema)

SignaBlok > News > SignaBlok, in collaboration with the University of Texas at Tyler, awarded NHLBI / NIH CATALYZE grant to develop a novel treatment for pleural infection (empyema)

SignaBlok, in collaboration with the University of Texas at Tyler, awarded NHLBI / NIH CATALYZE grant to develop a novel treatment for pleural infection (empyema)

Vera

View posts by Vera